CD30 CAR-T

· Shandong Qilu Cell Therapy Engineering Technology Co., Ltd

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for CD30 CAR-T, covering 2022-04-11 to 2026-01-06. Get the full timeline:

Most recent: Clinical Trial Update: Study of CD30 CAR for Relapsed/Refractory CD30+ HL and CD30+ NHL [Phase 1, Phase 2]